HMGB1, an innate alarmin, plays a critical role in chronic inflammation of adipose tissue in obesity

Molecular and Cellular Endocrinology

Volumn 454, Issue , 2017, Pages 103-111

  Zhang, Jing ^a   Zhang, Lei ^a   Zhang, Shu ^a   Yu, Qilin ^a   Xiong, Fei ^a   Huang, Kun ^b   Wang, Cong Yi ^a   Yang, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adipocyte; Alarmin; DC; HMGB1; Macrophage; Obesity; RAGE; TLRs

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; ALARMIN;

ADIPOCYTE; ADIPOSE TISSUE; CELL DEATH; CHRONIC INFLAMMATION; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; INTRAPERITONEAL FAT; MACROPHAGE; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; CHEMISTRY; CHRONIC DISEASE; INFLAMMATION; METABOLISM; PATHOLOGY;

ADIPOSE TISSUE; ALARMINS; ANIMALS; CHRONIC DISEASE; HMGB1 PROTEIN; HUMANS; INFLAMMATION; OBESITY;

EID: 85021091181     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2017.06.012     Document Type: Review

References (121)

1. Abraham, E., Arcaroli, J., Carmody, A., Wang, H., Tracey, K.J., Hmg-1 as a mediator of acute lung inflammation. J. Immunol. 165 (2000), 2950–2954.
2. Andersson, U., Tracey, K.J., Hmgb1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. Rheumat. Dis. Clin. N. Am. 30 (2004), 627–637 xi.
3. Andersson, U., Tracey, K.J., Hmgb1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29 (2011), 139–162.
4. Antoine, D.J., Harris, H.E., Andersson, U., Tracey, K.J., Bianchi, M.E., A systematic nomenclature for the redox states of high mobility group box (hmgb) proteins. Mol. Med. 20 (2014), 135–137.
5. Arrigo, T., Chirico, V., Salpietro, V., Munafo, C., Ferrau, V., Gitto, E., Lacquaniti, A., Salpietro, C., High-mobility group protein b1: a new biomarker of metabolic syndrome in obese children. Eur. J. Endocrinol. 168 (2013), 631–638.
6. Barkauskaite, V., Ek, M., Popovic, K., Harris, H.E., Wahren-Herlenius, M., Nyberg, F., Translocation of the novel cytokine hmgb1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally uv-induced lesions of cutaneous lupus erythematosus. Lupus 16 (2007), 794–802.
7. Bertheloot, D., Latz, E., Hmgb1, il-1alpha, il-33 and s100 proteins: dual-function alarmins. Cell. Mol. Immunol. 14 (2017), 43–64.
8. Bertola, A., Ciucci, T., Rousseau, D., Bourlier, V., Duffaut, C., Bonnafous, S., Blin-Wakkach, C., Anty, R., Iannelli, A., Gugenheim, J., Tran, A., Bouloumie, A., Gual, P., Wakkach, A., Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing th17 responses in mice and patients. Diabetes 61 (2012), 2238–2247.
9. Bianchi, M.E., Beltrame, M., Paonessa, G., Specific recognition of cruciform DNA by nuclear protein hmg1. Science 243 (1989), 1056–1059.
10. Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., Bianchi, M.E., Monocytic cells hyperacetylate chromatin protein hmgb1 to redirect it towards secretion. EMBO J. 22 (2003), 5551–5560.
11. Calogero, S., Grassi, F., Aguzzi, A., Voigtlander, T., Ferrier, P., Ferrari, S., Bianchi, M.E., The lack of chromosomal protein hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 22 (1999), 276–280.
12. Cancello, R., Clement, K., Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG Int. J. Obstetr. Gynaecol. 113 (2006), 1141–1147.
13. Chen, M., Huang, W., Wang, C., Nie, H., Li, G., Sun, T., Yang, F., Zhang, Y., Shu, K., Wang, C., Gong, Q., High-mobility group box 1 exacerbates ccl(4)-induced acute liver injury in mice. Clin. Immunol. 153 (2014), 56–63.
14. Chen, Y., Pitzer, A.L., Li, X., Li, P.L., Wang, L., Zhang, Y., Instigation of endothelial nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of hmgb1. J. Cell. Mol. Med. 19 (2015), 2715–2727.
15. Cheng, J., Song, J., He, X., Zhang, M., Hu, S., Zhang, S., Yu, Q., Yang, P., Xiong, F., Wang, D.W., Zhou, J., Ning, Q., Chen, Z., Eizirik, D.L., Zhou, Z., Zhao, C., Wang, C.Y., Loss of mbd2 protects mice against high-fat diet-induced obesity and insulin resistance by regulating the homeostasis of energy storage and expenditure. Diabetes 65 (2016), 3384–3395.
16. Cildir, G., Akincilar, S.C., Tergaonkar, V., Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol. Med. 19 (2013), 487–500.
17. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S., Obin, M.S., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. lipid Res. 46 (2005), 2347–2355.
18. Cobb, W.S., Burns, J.M., Kercher, K.W., Matthews, B.D., James Norton, H., Todd Heniford, B., Normal intraabdominal pressure in healthy adults. J. Surg. Res. 129 (2005), 231–235.
19. Dumitriu, I.E., Baruah, P., Valentinis, B., Voll, R.E., Herrmann, M., Nawroth, P.P., Arnold, B., Bianchi, M.E., Manfredi, A.A., Rovere-Querini, P., Release of high mobility group box 1 by dendritic cells controls t cell activation via the receptor for advanced glycation end products. J. Immunol. 174 (2005), 7506–7515.
20. Eichelmann, F., Schwingshackl, L., Fedirko, V., Aleksandrova, K., Effect of plant-based diets on obesity-related inflammatory profiles: a systematic review and meta-analysis of intervention trials. Obes. Rev. Off. J. Int. Assoc. Study Obes. 17 (2016), 1067–1079.
21. Evankovich, J., Cho, S.W., Zhang, R., Cardinal, J., Dhupar, R., Zhang, L., Klune, J.R., Zlotnicki, J., Billiar, T., Tsung, A., High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J. Biol. Chem. 285 (2010), 39888–39897.
22. Feng, H., Yu, L., Zhang, G., Liu, G., Yang, C., Wang, H., Song, X., Regulation of autophagy-related protein and cell differentiation by high mobility group box 1 protein in adipocytes. Mediat. Inflamm., 2016, 2016, 1936386.
23. Ferrante, A.W. Jr., Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 262 (2007), 408–414.
24. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A.B., Benoist, C., Shoelson, S., Mathis, D., Lean, but not obese, fat is enriched for a unique population of regulatory t cells that affect metabolic parameters. Nat. Med. 15 (2009), 930–939.
25. Foretz, M., Guigas, B., Bertrand, L., Pollak, M., Viollet, B., Metformin: from mechanisms of action to therapies. Cell metab. 20 (2014), 953–966.
26. Gardella, S., Andrei, C., Ferrera, D., Lotti, L.V., Torrisi, M.R., Bianchi, M.E., Rubartelli, A., The nuclear protein hmgb1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3 (2002), 995–1001.
27. Gesta, S., Tseng, Y.H., Kahn, C.R., Developmental origin of fat: tracking obesity to its source. Cell 131 (2007), 242–256.
28. Ghosh, A.R., Bhattacharya, R., Bhattacharya, S., Nargis, T., Rahaman, O., Duttagupta, P., Raychaudhuri, D., Liu, C.S., Roy, S., Ghosh, P., Khanna, S., Chaudhuri, T., Tantia, O., Haak, S., Bandyopadhyay, S., Mukhopadhyay, S., Chakrabarti, P., Ganguly, D., Adipose recruitment and activation of plasmacytoid dendritic cells fuel metaflammation. Diabetes 65 (2016), 3440–3452.
29. Giacobbe, A., Grasso, R., Imbesi, G., Salpietro, C.D., Grasso, L., Lagana, A.S., Triolo, O., Di Benedetto, A., High mobility group protein b1: a new biomarker of obesity in pregnant women?. Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol. 31 (2015), 113–115.
30. Goossens, G.H., The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol. Behav. 94 (2008), 206–218.
31. Greijer, A.E., van der Wall, E., The role of hypoxia inducible factor 1 (hif-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57 (2004), 1009–1014.
32. Gunasekaran, M.K., Virama-Latchoumy, A.L., Girard, A.C., Planesse, C., Guerin-Dubourg, A., Ottosson, L., Andersson, U., Cesari, M., Roche, R., Hoareau, L., Tlr4-dependant pro-inflammatory effects of hmgb1 on human adipocyte. Adipocyte 5 (2016), 384–388.
33. Gunasekaran, M.K., Viranaicken, W., Girard, A.C., Festy, F., Cesari, M., Roche, R., Hoareau, L., Inflammation triggers high mobility group box 1 (hmgb1) secretion in adipose tissue, a potential link to obesity. Cytokine 64 (2013), 103–111.
34. Guzman-Ruiz, R., Ortega, F., Rodriguez, A., Vazquez-Martinez, R., Diaz-Ruiz, A., Garcia-Navarro, S., Giralt, M., Garcia-Rios, A., Cobo-Padilla, D., Tinahones, F.J., Lopez-Miranda, J., Villarroya, F., Fruhbeck, G., Fernandez-Real, J.M., Malagon, M.M., Alarmin high-mobility group b1 (hmgb1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in beta-cells. Int. J. Obes. 38 (2014), 1545–1554.
35. Han, J., Zhong, J., Wei, W., Wang, Y., Huang, Y., Yang, P., Purohit, S., Dong, Z., Wang, M.H., She, J.X., Gong, F., Stern, D.M., Wang, C.Y., Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in nod mice. Diabetes 57 (2008), 2118–2127.
36. He, L., Sun, F., Wang, Y., Zhu, J., Fang, J., Zhang, S., Yu, Q., Gong, Q., Ren, B., Xiang, X., Chen, Z., Ning, Q., Hu, J., Yang, P., Wang, C.Y., Hmgb1 exacerbates bronchiolitis obliterans syndrome via rage/nf-kappab/hpse signaling to enhance latent tgf-beta release from ecm. Am. J. Transl. Res. 8 (2016), 1971–1984.
37. Helmlinger, G., Yuan, F., Dellian, M., Jain, R.K., Interstitial ph and po2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3 (1997), 177–182.
38. Holland, W.L., Bikman, B.T., Wang, L.P., Yuguang, G., Sargent, K.M., Bulchand, S., Knotts, T.A., Shui, G., Clegg, D.J., Wenk, M.R., Pagliassotti, M.J., Scherer, P.E., Summers, S.A., Lipid-induced insulin resistance mediated by the proinflammatory receptor tlr4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121 (2011), 1858–1870.
39. Horiuchi, T., Sakata, N., Narumi, Y., Kimura, T., Hayashi, T., Nagano, K., Liu, K., Nishibori, M., Tsukita, S., Yamada, T., Katagiri, H., Shirakawa, R., Horiuchi, H., Metformin directly binds the alarmin hmgb1 and inhibits its proinflammatory activity. J. Biol. Chem., 2017, 8436–8446.
40. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., Shimomura, I., Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56 (2007), 901–911.
41. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
42. Imai, T., Takakuwa, R., Marchand, S., Dentz, E., Bornert, J.M., Messaddeq, N., Wendling, O., Mark, M., Desvergne, B., Wahli, W., Chambon, P., Metzger, D., Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 4543–4547.
43. Ito, I., Fukazawa, J., Yoshida, M., Post-translational methylation of high mobility group box 1 (hmgb1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 282 (2007), 16336–16344.
44. Izuishi, K., Tsung, A., Jeyabalan, G., Critchlow, N.D., Li, J., Tracey, K.J., Demarco, R.A., Lotze, M.T., Fink, M.P., Geller, D.A., Billiar, T.R., Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J. Immunol. 176 (2006), 7154–7158.
45. Janeway, C.A. Jr., Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 20 (2002), 197–216.
46. Javaherian, K., Liu, J.F., Wang, J.C., Nonhistone proteins hmg1 and hmg2 change the DNA helical structure. Science 199 (1978), 1345–1346.
47. Jialal, I., Kaur, H., Devaraj, S., Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J. Clin. Endocrinol. Metabol. 99 (2014), 39–48.
48. Jin, C., Henao-Mejia, J., Flavell, R.A., Innate immune receptors: key regulators of metabolic disease progression. Cell metab. 17 (2013), 873–882.
49. Kammoun, H.L., Kraakman, M.J., Febbraio, M.A., Adipose tissue inflammation in glucose metabolism. Rev. Endocr. Metabol. Disord. 15 (2014), 31–44.
50. Kanellakis, P., Agrotis, A., Kyaw, T.S., Koulis, C., Ahrens, I., Mori, S., Takahashi, H.K., Liu, K., Peter, K., Nishibori, M., Bobik, A., High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler., Thromb., Vasc. Biol. 31 (2011), 313–319.
51. Konner, A.C., Bruning, J.C., Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol. Metabol. TEM 22 (2011), 16–23.
52. Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J.F., Lei, J., Zechner, R., Ferrante, A.W. Jr., Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 120 (2010), 3466–3479.
53. Koumenis, C., Naczki, C., Koritzinsky, M., Rastani, S., Diehl, A., Sonenberg, N., Koromilas, A., Wouters, B.G., Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase perk and phosphorylation of the translation initiation factor eif2alpha. Mol. Cell. Biol. 22 (2002), 7405–7416.
54. Lago, F., Gomez, R., Gomez-Reino, J.J., Dieguez, C., Gualillo, O., Adipokines as novel modulators of lipid metabolism. Trends Biochem. Sci. 34 (2009), 500–510.
55. Lambert, D.M., Marceau, S., Forse, R.A., Intra-abdominal pressure in the morbidly obese. Obes. Surg. 15 (2005), 1225–1232.
56. Leist, M., Jaattela, M., Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2 (2001), 589–598.
57. Li, J., Gong, Q., Zhong, S., Wang, L., Guo, H., Xiang, Y., Ichim, T.E., Wang, C.Y., Chen, S., Gong, F., Chen, G., Neutralization of the extracellular hmgb1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol. Dial., Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 26 (2011), 469–478.
58. Lian, Y.J., Gong, H., Wu, T.Y., Su, W.J., Zhang, Y., Yang, Y.Y., Peng, W., Zhang, T., Zhou, J.R., Jiang, C.L., Wang, Y.X., Ds-hmgb1 and fr-hmgb induce depressive behavior through neuroinflammation in contrast to nonoxid-hmgb1. Brain, Behav. Immun. 59 (2017), 322–332.
59. Liaw, P.C., Ito, T., Iba, T., Thachil, J., Zeerleder, S., Damp and dic: the role of extracellular DNA and DNA-binding proteins in the pathogenesis of dic. Blood Rev. 30 (2016), 257–261.
60. Lopez-Diez, R., Shekhtman, A., Ramasamy, R., Schmidt, A.M., Cellular mechanisms and consequences of glycation in atherosclerosis and obesity. Biochim. Biophys. acta 1862 (2016), 2244–2252.
61. Lu, B., Antoine, D.J., Kwan, K., Lundback, P., Wahamaa, H., Schierbeck, H., Robinson, M., Van Zoelen, M.A., Yang, H., Li, J., Erlandsson-Harris, H., Chavan, S.S., Wang, H., Andersson, U., Tracey, K.J., Jak/stat1 signaling promotes hmgb1 hyperacetylation and nuclear translocation. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 3068–3073.
62. Lumeng, C.N., Innate immune activation in obesity. Mol. Asp. Med. 34 (2013), 12–29.
63. Lumeng, C.N., Bodzin, J.L., Saltiel, A.R., Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117 (2007), 175–184.
64. Magna, M., Pisetsky, D.S., The alarmin properties of DNA and DNA-associated nuclear proteins. Clin. Ther. 38 (2016), 1029–1041.
65. Malbrain, M.L., Chiumello, D., Pelosi, P., Wilmer, A., Brienza, N., Malcangi, V., Bihari, D., Innes, R., Cohen, J., Singer, P., Japiassu, A., Kurtop, E., De Keulenaer, B.L., Daelemans, R., Del Turco, M., Cosimini, P., Ranieri, M., Jacquet, L., Laterre, P.F., Gattinoni, L., Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive care Med. 30 (2004), 822–829.
66. Mathis, D., Immunological goings-on in visceral adipose tissue. Cell metab. 17 (2013), 851–859.
67. Messmer, D., Yang, H., Telusma, G., Knoll, F., Li, J., Messmer, B., Tracey, K.J., Chiorazzi, N., High mobility group box protein 1: an endogenous signal for dendritic cell maturation and th1 polarization. J. Immunol. 173 (2004), 307–313.
68. Monteiro, R., de Castro, P.M., Calhau, C., Azevedo, I., Adipocyte size and liability to cell death. Obes. Surg. 16 (2006), 804–806.
69. Montes, V.N., Subramanian, S., Goodspeed, L., Wang, S.A., Omer, M., Bobik, A., Teshigawara, K., Nishibori, M., Chait, A., Anti-hmgb1 antibody reduces weight gain in mice fed a high-fat diet. Nutr. diabetes, 5, 2015, e161.
70. Muller, G., Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes, Metabol. Syndr. Obes. Targets Ther. 5 (2012), 247–282.
71. Nativel, B., Marimoutou, M., Thon-Hon, V.G., Gunasekaran, M.K., Andries, J., Stanislas, G., Planesse, C., Da Silva, C.R., Cesari, M., Iwema, T., Gasque, P., Viranaicken, W., Soluble hmgb1 is a novel adipokine stimulating il-6 secretion through rage receptor in sw872 preadipocyte cell line: contribution to chronic inflammation in fat tissue. PloS One, 8, 2013, e76039.
72. Nguyen, M.T., Favelyukis, S., Nguyen, A.K., Reichart, D., Scott, P.A., Jenn, A., Liu-Bryan, R., Glass, C.K., Neels, J.G., Olefsky, J.M., A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and jnk-dependent pathways. J. Biol. Chem. 282 (2007), 35279–35292.
73. Odegaard, J.I., Chawla, A., Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6 (2011), 275–297.
74. Oh, Y.J., Youn, J.H., Ji, Y., Lee, S.E., Lim, K.J., Choi, J.E., Shin, J.S., Hmgb1 is phosphorylated by classical protein kinase c and is secreted by a calcium-dependent mechanism. J. Immunol. 182 (2009), 5800–5809.
75. Olefsky, J.M., Glass, C.K., Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72 (2010), 219–246.
76. Orr, J.S., Puglisi, M.J., Ellacott, K.L., Lumeng, C.N., Wasserman, D.H., Hasty, A.H., Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages. Diabetes 61 (2012), 2718–2727.
77. Osborn, O., Olefsky, J.M., The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18 (2012), 363–374.
78. Park, J.S., Arcaroli, J., Yum, H.K., Yang, H., Wang, H., Yang, K.Y., Choe, K.H., Strassheim, D., Pitts, T.M., Tracey, K.J., Abraham, E., Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284 (2003), C870–C879.
79. Park, J.S., Svetkauskaite, D., He, Q., Kim, J.Y., Strassheim, D., Ishizaka, A., Abraham, E., Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279 (2004), 7370–7377.
80. Parrizas, M., Novials, A., Circulating micrornas as biomarkers for metabolic disease. Best Pract. Res. Clin. Endocrinol. Metabol. 30 (2016), 591–601.
81. Poggi, M., Bastelica, D., Gual, P., Iglesias, M.A., Gremeaux, T., Knauf, C., Peiretti, F., Verdier, M., Juhan-Vague, I., Tanti, J.F., Burcelin, R., Alessi, M.C., C3h/hej mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50 (2007), 1267–1276.
82. Popovic, K., Ek, M., Espinosa, A., Padyukov, L., Harris, H.E., Wahren-Herlenius, M., Nyberg, F., Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheumat. 52 (2005), 3639–3645.
83. Rausch, M.E., Weisberg, S., Vardhana, P., Tortoriello, D.V., Obesity in c57bl/6j mice is characterized by adipose tissue hypoxia and cytotoxic t-cell infiltration. Int. J. Obes. 32 (2008), 451–463.
84. Rhee, I., Diverse macrophages polarization in tumor microenvironment. Archiv. Pharmacal Res. 39 (2016), 1588–1596.
85. Rockenfeller, P., Ring, J., Muschett, V., Beranek, A., Buettner, S., Carmona-Gutierrez, D., Eisenberg, T., Khoury, C., Rechberger, G., Kohlwein, S.D., Kroemer, G., Madeo, F., Fatty acids trigger mitochondrion-dependent necrosis. Cell cycle 9 (2010), 2836–2842.
86. Saberi, M., Woods, N.B., de Luca, C., Schenk, S., Lu, J.C., Bandyopadhyay, G., Verma, I.M., Olefsky, J.M., Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell metab. 10 (2009), 419–429.
87. Samad, F., Ruf, W., Inflammation, obesity, and thrombosis. Blood 122 (2013), 3415–3422.
88. Scaffidi, P., Misteli, T., Bianchi, M.E., Release of chromatin protein hmgb1 by necrotic cells triggers inflammation. Nature 418 (2002), 191–195.
89. Schmidt, A.M., 2016 atvb plenary lecture: receptor for advanced glycation endproducts and implications for the pathogenesis an treatment of cardiometabolic disorders: spotlight on the macrophage. Arterioscler., Thromb., Vasc. Biol., 2017.
90. Senn, J.J., Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 281 (2006), 26865–26875.
91. Shekhtman, A., Ramasamy, R., Schmidt, A.M., Glycation & the rage axis: targeting signal transduction through diaph1. Expert Rev. Proteom. 14 (2017), 147–156.
92. Shimizu, T., Yamakuchi, M., Biswas, K.K., Aryal, B., Yamada, S., Hashiguchi, T., Maruyama, I., Hmgb1 is secreted by 3t3-l1 adipocytes through jnk signaling and the secretion is partially inhibited by adiponectin. Obesity 24 (2016), 1913–1921.
93. Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122 (2012), 787–795.
94. Strissel, K.J., Stancheva, Z., Miyoshi, H., Perfield, J.W. 2nd, DeFuria, J., Jick, Z., Greenberg, A.S., Obin, M.S., Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 56 (2007), 2910–2918.
95. Subramanian V., Ferrante, A.W., Jr., 2009, Obesity, inflammation, and macrophages. Nestle Nutrition workshop series. Paediatric programme 63, 151–159; discussion 159-162, 259-168.
96. Suganami, T., Mieda, T., Itoh, M., Shimoda, Y., Kamei, Y., Ogawa, Y., Attenuation of obesity-induced adipose tissue inflammation in c3h/hej mice carrying a toll-like receptor 4 mutation. Biochem. Biophys. Res. Commun. 354 (2007), 45–49.
97. Tang, Y., Zhao, X., Antoine, D., Xiao, X., Wang, H., Andersson, U., Billiar, T.R., Tracey, K.J., Lu, B., Regulation of posttranslational modifications of hmgb1 during immune responses. Antioxid. redox Signal. 24 (2016), 620–634.
98. Telusma, G., Datta, S., Mihajlov, I., Ma, W., Li, J., Yang, H., Newman, W., Messmer, B.T., Minev, B., Schmidt-Wolf, I.G., Tracey, K.J., Chiorazzi, N., Messmer, D., Dendritic cell activating peptides induce distinct cytokine profiles. Int. Immunol. 18 (2006), 1563–1573.
99. Tsukumo, D.M., Carvalho-Filho, M.A., Carvalheira, J.B., Prada, P.O., Hirabara, S.M., Schenka, A.A., Araujo, E.P., Vassallo, J., Curi, R., Velloso, L.A., Saad, M.J., Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56 (2007), 1986–1998.
100. Tsukumo, D.M., Carvalho-Filho, M.A., Carvalheira, J.B., Prada, P.O., Hirabara, S.M., Schenka, A.A., Araujo, E.P., Vassallo, J., Curi, R., Velloso, L.A., Saad, M.J., Statement of retraction. Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007:56 (2016), 1986–1998, 10.2337/db06-1595 Diabetes 65, 1126-1127.
101. Tsung, A., Klune, J.R., Zhang, X., Jeyabalan, G., Cao, Z., Peng, X., Stolz, D.B., Geller, D.A., Rosengart, M.R., Billiar, T.R., Hmgb1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J. Exp. Med. 204 (2007), 2913–2923.
102. van Beijnum, J.R., Buurman, W.A., Griffioen, A.W., Convergence and amplification of toll-like receptor (tlr) and receptor for advanced glycation end products (rage) signaling pathways via high mobility group b1 (hmgb1). Angiogenesis 11 (2008), 91–99.
103. Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D.J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., Shams, S.S., Yang, H., Varani, L., Andersson, U., Tracey, K.J., Bachi, A., Uguccioni, M., Bianchi, M.E., Mutually exclusive redox forms of hmgb1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 209 (2012), 1519–1528.
104. Venereau, E., Ceriotti, C., Bianchi, M.E., Damps from cell death to new life. Front. Immunol., 6, 2015, 422.
105. Venereau, E., Schiraldi, M., Uguccioni, M., Bianchi, M.E., Hmgb1 and leukocyte migration during trauma and sterile inflammation. Mol. Immunol. 55 (2013), 76–82.
106. Ventura, J.J., Cogswell, P., Flavell, R.A., Baldwin, A.S. Jr., Davis, R.J., Jnk potentiates tnf-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes & Dev. 18 (2004), 2905–2915.
107. Wagner, M., A dangerous duo in adipose tissue: high-mobility group box 1 protein and macrophages. Yale J. Biol. Med. 87 (2014), 127–133.
108. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J.M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K.R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P.E., Abumrad, N.N., Sama, A., Tracey, K.J., Hmg-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999), 248–251.
109. Wang, H., Qu, H., Deng, H., Plasma hmgb-1 levels in subjects with obesity and type 2 diabetes: a cross-sectional study in China. PloS One, 10, 2015, e0136564.
110. Wang, L., Chen, Y., Li, X., Zhang, Y., Gulbins, E., Zhang, Y., Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin b-mediated nlrp3 inflammasome activation. Oncotarget 7 (2016), 73229–73241.
111. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante, A.W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003), 1796–1808.
112. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., Maezawa, Y., Drucker, D.J., Engleman, E., Winer, D., Dosch, H.M., Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15 (2009), 921–929.
113. Wozniak, S.E., Gee, L.L., Wachtel, M.S., Frezza, E.E., Adipose tissue: the new endocrine organ? A review article. Dig. Dis. Sci. 54 (2009), 1847–1856.
114. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003), 1821–1830.
115. Yan, S.D., Schmidt, A.M., Anderson, G.M., Zhang, J., Brett, J., Zou, Y.S., Pinsky, D., Stern, D., Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269 (1994), 9889–9897.
116. Yao, Y., Wang, Y., Zhang, Z., He, L., Zhu, J., Zhang, M., He, X., Cheng, Z., Ao, Q., Cao, Y., Yang, P., Su, Y., Zhao, J., Zhang, S., Yu, Q., Ning, Q., Xiang, X., Xiong, W., Wang, C.Y., Xu, Y., Chop deficiency protects mice against bleomycin-induced pulmonary fibrosis by attenuating m2 macrophage production. Mol. Ther. J. Am. Soc. Gene Ther. 24 (2016), 915–925.
117. Ye, J., Gao, Z., Yin, J., He, Q., Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metabol. 293 (2007), E1118–E1128.
118. Youn, J.H., Shin, J.S., Nucleocytoplasmic shuttling of hmgb1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 177 (2006), 7889–7897.
119. Zhang, X., Wheeler, D., Tang, Y., Guo, L., Shapiro, R.A., Ribar, T.J., Means, A.R., Billiar, T.R., Angus, D.C., Rosengart, M.R., Calcium/calmodulin-dependent protein kinase (camk) iv mediates nucleocytoplasmic shuttling and release of hmgb1 during lipopolysaccharide stimulation of macrophages. J. Immunol. 181 (2008), 5015–5023.
120. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994), 425–432.
121. Ziegler, U., Groscurth, P., Morphological features of cell death. News Physiol. Sci. Int. J. Physiol. Prod. jointly by Int. Union Physiol. Sci. Am. Physiol. Soc. 19 (2004), 124–128.